eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients.

 

We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release.

 

Our new 65,000sqft Cell & Gene Therapy Centre has GMP Clean Rooms and Fill Finish capabilities for Viral Vectors, Autologous & Allogenic Cell Therapies and RNA Technologies.

 

We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the chances of product success. 

OUR SERVICES

eXmoor pharma in numbers

We listen. We put your interests first, by ensuring that what we do links with your business strategy. We value knowledge sharing and innovation – free thinking in a structured environment. We like to work as trusted members of an integrated, high performance team. We welcome feedback on our performance.

65,000 ft²

GMP FACILITY

Dedicated Process and Analytical, GMP and QC laboratories

150+

CLIENTS

Over 150 CGT and biopharma clients

530

INDIVIDUAL PROJECTS

eXmoor has completed over 500 cell therapy and biopharma projects

500

YEARS’ COMBINED EXPERIENCE

eXmoor has a team with around 500 years’ combined experience

70%

REPEAT BUSINESS

Currently multiple projects with more than 70% of clients

4

GMP CLEAN ROOMS

4 Grade C clean rooms including a dedicated Fill Finish suite

45

FACILITY DESIGNS

eXmoor has designed 45 cell & gene therapy and biopharma facilities globally

8

QP ROLES

eXmoor is currently named on the license as QP for 8 facilities

“eXmoor was an integral part of a collaborative partnership to design and deliver a world-leading industry development environment, with inherent flexibility, to develop and test innovative cell and gene therapy processes.”

COO, Cell and Gene Therapy Catapult

“Quell and eXmoor have worked productively and successfully together for several years, and we are excited to extend our relationship with them to support our clinical manufacturing needs.”

Chief Manufacturing Officer, Quell Therapeutics

“We contracted eXmoor to rapidly perform a feasibility assessment on a potential expansion project we were interested in pursuing. The eXmoor team understood the business drivers for this approach and delivered a clear and well thought out package that really helped with our assessment of the opportunity.

The eXmoor team is very skilled, experienced and professional and were well placed to provide this early feasibility work, as well as more comprehensive packages of work to support more advanced projects.”

Senior Manager, UK Gene Therapy Company

“The most important thing for us is to work in partnership with our consultants and eXmoor really feels like a vital part of the team. Their client focused and agile approach to project management has meant that we can trust and rely on them to deliver the very best advice and solutions to meet our needs.

eXmoor draws on experience from many different disciplines including facility design and engineering, operational effectiveness and team structure. This has increased the value of everything they do for us as it feels like we are tapping into a wider team. In particular, their expertise in cell and gene therapy has been invaluable to us and we can’t thank them enough for their continued QP support, which is vital for our BDU, not just for product certification, but also for general GMP compliance questions.”

Head of Biotherapeutics Development Unit, Cancer Research UK